Amazon Souq acquisition : US online retail giant to buy Middle East online shopping site

businessnewstoday- March 29, 2017

Amazon Souq acquisition news : Ending days of speculation, e-commerce giant Amazon has finally announced its acquisition of, a well-known online retailer in the ... Read More

Lilly’s breast cancer drug abemaciclib meets objective in phase 3 trial

pharmanewsdaily- March 22, 2017

Indianapolis-based Lilly has reported that its breast cancer drug, abemaciclib, in combination with fulvestrant, has yielded positive results by meeting its primary endpoint, progression-free survival ... Read More

New oral blood thinner rivaroxaban from Bayer and Jannsen shown to cut recurrence of life-threatening blood clots

pharmanewsdaily- March 19, 2017

Bayer and Janssen Pharmaceuticals have revealed that their jointly developed oral blood thinner Xarelto (rivaroxaban) had considerably brought down the risk of recurring formation of ... Read More

Astrazeneca ovarian cancer drug Lynparza shown to improve survival chances

pharmanewsdaily- March 18, 2017

Pharma giant AstraZeneca has reported that its ovarian cancer drug Lynparza (olaparib) as a maintenance therapy has considerably improved the survival chances of patients with ... Read More

Amgen cholesterol injection Repatha reduces heart attack, stroke chances

pharmanewsdaily- March 18, 2017

Amgen cholesterol injection Repatha (evolocumab) has been demonstrated to have cut heart attack and stroke risk by 20% in a phase 3 cardiovascular outcomes study ... Read More

Tigenix’ heart attack stem cell therapy trial delivers positive results

pharmanewsdaily- March 13, 2017

TiGenix has announced that its cardiac stem cell study assessing its heart attack stem cell therapy with AlloCSC-01 was successful in patients having the risk of ... Read More

Servier, Pfizer given FDA green signal for lymphoblastic leukemia drug

pharmanewsdaily- March 12, 2017

The US Food and Drug Administration (FDA) has given the green signal to Servier and Pfizer to carry out the clinical development of their UCART19 ... Read More

Actelion’s Ledaga Chlormethine Gel for CTCL MF treatment gets EC approval

pharmanewsdaily- March 11, 2017

Actelion recent news : The European Commission (EC) has approved Actelion Pharmaceuticals' marketing authorization for its Ledaga Chlormethine Gel 160 micrograms/g for cutaneous T-cell lymphoma ... Read More

AstraZeneca, Sanofi form R&D alliance for infant respiratory drug

pharmanewsdaily- March 6, 2017

AstraZeneca’s MedImmune and Sanofi Pasteur have formed a research and development alliance for a new infant respiratory drug, MEDI8897 which they are planning to commercialize ... Read More

Noctiva becomes first FDA approved treatment for nocturia syndrome

pharmanewsdaily- March 5, 2017

Serenity Pharmaceuticals’ nasal spray to treat the nocturnal polyuria syndrome in adults, Noctiva (desmopressin acetate) has secured the US FDA approval. Nocturnal polyuria syndrome or ... Read More